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1. Introduction 
The presence of a disaccharide chain composed of 
D-galactose and 2-acetamido-2-deoxy-D-galactose resi- 
dues attached by an 0glycosyl linkage to serine or 
threonine in the protein backbone has been reported 
for many animal glycoproteins, including epiglycanin 
from the TA3-Ha mammary carcinoma ascites cell 
[ I 1, as well as glycoproteins from rat brain [2], rabbit 
brain [3], antarctic [4] and arctic [5] fish, and fetuin 
from fetal calf serum [6]. The determination of the 
configuration at the anomeric carbon atom of the 
D-galactopyranosyl residue (of the isolated reduced 
disaccharide) has often been equivocal, due to the 
resistance of the D-Gal+D-GalNAc-ol bond to cleav- 
age by either (Y- or /3-galactosidases [2,3,7]. Since the 
complete or partial cleavage by /3-galactosidases 
reported in a few cases [4,6,8] was obtained only 
with difficulty, an unequivocal proof for the config- 
uration of this linkage was necessary. 
Following the work in [ 1,7], the presence of the 
@-anomer of the D-galactose residue of the disaccharide 
was considered likely. This was mainly on the basis of 
the strong inhibitory activity for the hemagglutina- 
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tion of human erythrocytes of N blood-group specif- 
icity by the lectin from b’iciu graminea seeds, an 
activity that had been attributed to a structure of this 
type [9], although without strong evidence. In addi- 
tion, the occurrence of a terminal sialic acid residue 
attached to an a-D-linked galactose residue had not, 
to our knowledge, been demonstrated to occur in 
mammalian systems [2], and the presence of an 
N-acetylneuraminic acid residue attached to a D-galac- 
tose residue in the disaccharide had been suggested as 
a second chain type in epiglycanin [ 11. 
Because of the high proportion of the disaccharide 
chains in epiglycanin, it was possible to obtain a suffi- 
cient amount of material for a definitive determina- 
tion of the configuration of the anomeric carbon of 
the D-galactose residue by NMR. These results have 
shown that the galactose residue is in the P-D-form, 
and that the disaccharide has the structure, 2-acetamido- 
2-deoxy-3-O-(fi-D-galactopyranosyl)-D-galactose, as 
shown in fig-l. 
Fig.1 
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2. Materials and methods 
The reduced disaccharide, DGal+DGalNAc-ol, 
was obtained by alkaline cleavage from epiglycanin 
[ 1 J under reductive conditions (NaBH,) and subse- 
quent purification by ion-exchange and gel-filtration 
chromatography, as in [lo]. The NMR spectra were 
recorded on a Varian FT-80 instrument at 30 rev./s 
and 22°C. Chemical shifts (6) are relative to sodium 
2,2-dimethyl-2-sila pentaneJ-sulfonate. The spectrum 
of the reduced disaccharide (2.6 mg) in ‘Hz0 was 
recorded after 1014 scans. This material was then 
dried and peracetylated with 0.1 ml acetic anhydride 
and 0.8 ml dry pyridine for 38 h at 22°C. The result- 
ing amorphous product was dried extensively 
in vacua, dissolved in C%CL3, and its NMR spec- 
trum recorded after 1030 scans, as above. 
3. Results and discussion 
Epiglycanin, the major glycoprotein of the TA3-Ha 
mammary carcinoma ascites cell, consists of -530 
carbohydrate chains attached to a single extended 
polypeptide chain of -1300 amino acid residues 
[ 1,7]. Its molecular weight, as determined by sedi- 
mentation equilibrium, and confirmed by electron 
microscopic measurements [ll], is -500 000. By 
alkaline borohydride reduction of epiglycanin [ 11, 
followed by ionexchange and gel-filtration chro- 
matography, it has been possible to isolate from 
epiglycanin [ 11, five different reduced oligosaccha- 
rides. each representing a different chain structure 
[lo]. The most abundant of the chains, a disaccharide 
of Gal and GalNAc in equimolar proportions, was 
found to comprise -60% of the total number of the 
carbohydrate chains, isolated in reduced form. By 
permethylation, followed by gas-liquid chromatog- 
raphy-mass spectrometry, the Gal was shown to be 
1-3~linked to the GalNAc-ol [lo]. 
The results of NMR spectroscopy for the reduced 
disaccharide and its peracetylated derivative are pre- 
sented in table 1. The J12 values (7.25 Hz) are identi- 
cal and are consistent with a fl-Dconfiguration for the 
galactose residue [ 121. The chemical shift of the H-l 
signal of the unsubstituted disaccharide (4.46 ppm) is 
approximately at the expected position for the 
fl-anomer. A chemical shift of 4.68 ppm for B-D-galac- 
tose was observed [ 131, whereas 5.34 ppm was 
obtained for the Ly-anomer. The downfield shift of 
the H-l signal from 4.46-5.12 ppm upon acetylation 
was expected and was found to be identical (0.66 
ppm) to that observed in [ 141 upon acetylating methyl 
2-acetamido-2-deoxy-6-O@-D-galactopyranosyl)-a- 
D-glucopyranoside. These results clearly establish the 
&configuration for the D-galactopyranosyl residue 
of the disaccharide chain of epiglycanin. 
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